The new 4,000-square-foot facility comprises one of the most advanced probiotic technological research labs in the world, the company said. The facility’s capabilities range from strain selection and genetic identification to product development support and stability testing.
“Ganeden's lab facility enables us to serve as an R&D resource for our partners and clients. Through the use of our lab, our clients are able to bring top quality, well-researched products to market in a very short period of time,” said Mike Bush, Vice President, Business Development.
Ganeden manufactures a branded strain of bacillus coagulans called BC30. The strain’s spore forming properties and attendant attractive stability profile has enabled the company to place it in a wide variety of functional foods and beverages and even in baking applications. In 2011, Ganeden sold the probitoic supplements side of its business to Schiff Nutrition to focus solely on food applications.